VNDA Competitors & Alternatives
Compare Vanda Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
VNDA
Main Stock$6.21
Tradestie Score
58
Market Cap
$301.35M
Revenue Growth
0.0%
Analyst Upside
+127.5%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$15.64
|
$386.68M | - | 58 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.74
|
$382.04M | - | 53 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.23
|
$371.64M | - | 61 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$23.21
|
$357.51M | - | 54 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.63
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$33.43
|
$353.70M | - | 60 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$2.03
|
$350.98M | - | 57 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.16
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.46
|
$332.96M | - | 55 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.58
|
$328.62M | - | 58 | Compare |
More VNDA Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry